-
[1]
Y. Weng, J. Liu, S. Jin, et al., Acta Pharm. Sin. B 7 (2017) 281-291.
doi: 10.1016/j.apsb.2016.09.001
-
[2]
N.D. Sheybani, H. Yang, Chin. Chem. Lett. 28 (2017) 1817-1821.
doi: 10.1016/j.cclet.2017.07.022
-
[3]
A. Tuomela, P. Liu, J. Puranen, et al., Int. J. Pharm. 467 (2014) 34-41.
doi: 10.1016/j.ijpharm.2014.03.048
-
[4]
V.J. Rodríguez, V.L. Rodríguez, Int. J. Pharm. 531 (2017) 167-178.
doi: 10.1016/j.ijpharm.2017.08.067
-
[5]
D.R. Janagam, L. Wu, T.L. Lowe, Adv. Drug Deliv. Rev. 122 (2017) 31-64.
doi: 10.1016/j.addr.2017.04.001
-
[6]
M.L. Occhiutto, F.R. Freitas, R.C. Maranhao, V.P. Costa, Pharmaceutics 4 (2012) 252-275.
doi: 10.3390/pharmaceutics4020252
-
[7]
Y. Lu, J. Qi, W. Wu, Curr. Drug Metab. 13 (2012) 396-417.
doi: 10.2174/138920012800166544
-
[8]
W.H. Ji, Z.B. Xiao, G.Y. Liu, X. Zhang, Chin. Chem. Lett. 28 (2017) 1829-1834.
doi: 10.1016/j.cclet.2017.06.024
-
[9]
S. Akhter, S. Talegaonkar, Z.I. Khan, et al., J. Biomed. Nanotechnol. 7 (2011) 144-145.
doi: 10.1166/jbn.2011.1241
-
[10]
L. Ying, K. Tahara, H. Takeuchi, Int. J. Pharm. 453 (2013) 329-335.
doi: 10.1016/j.ijpharm.2013.06.024
-
[11]
M. Gallarate, D. Chirio, R. Bussano, et al., Int. J. Pharm. 440 (2013) 126-134.
doi: 10.1016/j.ijpharm.2012.10.015
-
[12]
M.J. Lawrence, G.D. Rees, Adv. Drug Deliv. Rev. 64 (2012) 175-193.
doi: 10.1016/j.addr.2012.09.018
-
[13]
A. Radomska-Soukharev, J. Wojciechowska, Acta Pol. Pharm. 62 (2005) 465-471.
-
[14]
Y. Lu, Y. Li, W. Wu, Acta Pharm. Sin. B 6 (2016) 106-113.
doi: 10.1016/j.apsb.2015.11.005
-
[15]
Y. Lu, J. Qi, X. Dong, W. Zhao, W. Wu, Drug Discov. Today 22 (2017) 744-750.
doi: 10.1016/j.drudis.2017.01.003
-
[16]
Y. Lu, Y. Chen, R.A. Gemeinhart, W. Wu, T. Li, Nanomedicine 10 (2015) 2537-2552.
doi: 10.2217/nnm.15.73
-
[17]
R.D. Bachu, P. Chowdhury, Z.H.F. Al-Saedi, P.K. Karla, S.H.S. Boddu, Pharmaceutics 10 (2018) 28.
doi: 10.3390/pharmaceutics10010028
-
[18]
A. Madni, M.A. Rahem, N. Tahir, et al., Int. J. Pharm. 530 (2017) 326-345.
doi: 10.1016/j.ijpharm.2017.07.065
-
[19]
M.R. Gigliobianco, C. Casadidio, R. Censi, P.D. Martino, Pharmaceutics 10 (2018) 134.
doi: 10.3390/pharmaceutics10030134
-
[20]
M. Kassem, A. Abdelrahman, M. Ghorab, M. Ahmed, R. Khalil, Int. J. Pharm. 340 (2007) 126-133.
doi: 10.1016/j.ijpharm.2007.03.011
-
[21]
Y. Diebold, M. Calonge, Prog. Retinal Eye Res. 29 (2010) 596-609.
doi: 10.1016/j.preteyeres.2010.08.002
-
[22]
X. Cai, S. Conley, M. Naash, Vision Res. 48 (2008) 319-324.
doi: 10.1016/j.visres.2007.07.012
-
[23]
D. Thassu, G.J. Chader, Ocular Drug Delivery Systems:Barriers and Application of Nanoparticulate Systems, 1st ed., CRC Press, Florida, 2012.
-
[24]
H. Hillaireau, P. Couvreur, Cell. Mol. Life Sci. 66 (2009) 2873-2896.
doi: 10.1007/s00018-009-0053-z
-
[25]
E. Sakurai, H. Ozeki, N. Kunou, Y. Ogura, Ophthalmic Res. 33 (2001) 31-36.
doi: 10.1159/000055638
-
[26]
K. Baba, Y. Tanaka, A. Kubota, et al., J. Control. Release 153 (2011) 278-287.
doi: 10.1016/j.jconrel.2011.04.019
-
[27]
B.C. Tian, W.J. Zhang, H.M. Xu, et al., Colloids Surf. B -Biointerfaces 102 (2013) 251-256.
doi: 10.1016/j.colsurfb.2012.08.021
-
[28]
S. Pretor, J. Bartels, T. Lorenz, et al., Mol. Pharm. 12 (2015) 34-45.
doi: 10.1021/mp500401t
-
[29]
X. Hu, X. Dong, Y. Lu, et al., Drug Discov. Today 22 (2017) 382-387.
doi: 10.1016/j.drudis.2016.10.002
-
[30]
X. Hu, J. Zhang, Z. Yu, et al., Nanomedicine 11 (2015) 1939-1948.
doi: 10.1016/j.nano.2015.06.013
-
[31]
X. Hu, W. Fan, Z. Yu, et al., Nanoscale 8 (2016) 7024-7035.
doi: 10.1039/C5NR07474F
-
[32]
R. Su, W. Fan, Q. Yu, et al., Oncotarget 8 (2017) 38214-38226.
-
[33]
F. Xia, W. Fan, S. Jiang, et al., ACS Appl. Mater. Interfaces 9 (2017) 21660-21672.
doi: 10.1021/acsami.7b04916
-
[34]
E. Ahmad, Y. Feng, J. Qi, et al., Nanoscale 9 (2017) 1174-1183.
doi: 10.1039/C6NR07581A
-
[35]
C. Shen, Y. Yang, B. Shen, et al., Nanoscale 10 (2017) 436-450.
-
[36]
Y. Xie, B. Shi, F. Xia, et al., J. Control. Release 270 (2018) 65-75.
doi: 10.1016/j.jconrel.2017.11.046
-
[37]
Y. Xie, X. Hu, H. He, et al., J. Mater. Chem. B -Mater. Biol. Med. 4 (2016) 2864-2873.
doi: 10.1039/C5TB02706C
-
[38]
B. Wan, Y. Dai, D. Liu, et al., J. Biomed. Nanotechnol. 13 (2017) 960-972.
doi: 10.1166/jbn.2017.2404
-
[39]
H. He, J. Zhang, Y. Xie, et al., Mol. Pharm. 13 (2016) 4013-4019.
doi: 10.1021/acs.molpharmaceut.6b00705
-
[40]
Z. Rahman, X. Xu, U. Katragadda, et al., Mol. Pharm. 11 (2014) 787-799.
doi: 10.1021/mp400484g
-
[41]
M.J.Newton Rimple, Recent Pat. Inflamm. Allergy Drug Discov. 12 (2018) 169-183.
doi: 10.2174/1872213X12666180730115225
-
[42]
C. Luschmann, W. Herrmann, O. Strauss, K. Luschmann, A. Goepferich, Int. J. Pharm. 455 (2013) 331-337.
doi: 10.1016/j.ijpharm.2013.07.002
-
[43]
H.D. Williams, N.L. Trevaskis, S.A. Charman, et al., Pharmacol. Rev. 65 (2013) 315-499.
doi: 10.1124/pr.112.005660
-
[44]
R.H. Müller, S. Gohla, C.M. Keck, Eur. J. Pharm. Biopharm. 78 (2011) 1-9.
doi: 10.1016/j.ejpb.2011.01.007
-
[45]
C.G. Park, Y.K. Kim, M.J. Kim, et al., J. Control. Release 220 (2015) 180-188.
doi: 10.1016/j.jconrel.2015.10.027
-
[46]
U.B. Kompella, A.C. Amrite, R. Pacha Ravi, S.A. Durazo, Prog. Retinal Eye Res. 36 (2013) 172-198.
doi: 10.1016/j.preteyeres.2013.04.001
-
[47]
M. Rawas-Qalaji, C.A. Williams, Curr. Eye Res. 37 (2012) 345-356.
doi: 10.3109/02713683.2011.652286
-
[48]
Y. Chen, Y. Lu, Y. Zhong, et al., J. Drug Target. 20 (2012) 856-863.
doi: 10.3109/1061186X.2012.723214